v3.26.1
RESTATEMENT OF THE COMPANY’S PREVIOUSLY ISSUED FINANCIAL STATEMENTS
12 Months Ended
Dec. 31, 2024
Restatement Of Companys Previously Issued Financial Statements  
RESTATEMENT OF THE COMPANY’S PREVIOUSLY ISSUED FINANCIAL STATEMENTS

NOTE 5 – RESTATEMENT OF THE COMPANY’S PREVIOUSLY ISSUED FINANCIAL STATEMENTS

 

During fiscal 2023, the Company reassessed its principal asset, its iTDE Technology, concluding that such technology was a finite intangible asset and applying retroactive amortization to the value of the asset. The annual reports of the Company for 2023 and 2024 both reflect the changes to the financial statements resulting from this re-evaluation. There were no changes to the intangible asset on the 10K previously filed on April 30, 2025.

 

The following table illustrates the result of the reclassification showing amortization applied since December 31, 2022:

 

Intangible Asset  iTDE Technology 
Cost     
At December 31, 2022   3,500,127 
Additions   - 
Transfers   - 
At December 31, 2023   3,500,127 
Additions   - 
Disposals   - 
At December 31, 2024   3,500,127 
      
Accumulated Amortization     
At December 31, 2022   658,378 
Charge for the year   149,782 
At December 31, 2023   808,160 
Charge for the year   149,782 
At December 31, 2024   957,942 
      
Carrying amount     
At December 31, 2023   2,691,967 
At December 31, 2024   2,542,185 

 

Balance Sheets
December 31, 2024

 

The following table presents the effect of the restatement adjustments on the balance sheet as of December 31, 2024:

 

   As Previously Reported   Adjustment Reference   Adjustment Amount  

 

As Restated

 
ASSETS                    
Current Assets:                    
Cash  $62,547           $62,547 
Investments   38,549    A    38,549    77,098 
Prepaid expense and other current assets   604,368    B    (523,102)   81,266 
Total Current Assets   705,464    A+B    (484,553)   220,911 
                     
Non-current Assets:                    
Property and equipment, net   7,285            7,285 
Intangible asset, net   2,542,185            2,542,185 
Total Non-current Assets   2,549,470            2,549,470 
                     
Total Assets  $3,254,934    A+B   $(484,553)  $2,770,381 
                     
LIABILITIES AND STOCKHOLDERS’ DEFICIT                    
Current Liabilities:                    
Accounts payable and accrued liabilities  $3,119,281        (16,027)  $3,103,254 
Other current liabilities   500,000            500,000 
Convertible notes payable – related party                
Loan payable   845,000    C    (845,000)    
Due to related party   107,445            107,445 
Total Current Liabilities   4,571,726        (861,027)   3,710,699 
                     
Non-current Liabilities:                    
Convertible notes payable   1,585,004    C    845,000    2,430,004 
Total Non-current Liabilities   1,585,004        845,000    2,430,004 
                     
Total Liabilities   6,156,730    D    (16,027)   6,140,703 
                     
Stockholders’ Equity (Deficit):                    
Preferred stock, $0.001 par value, 5,000,000 shares authorized, 40,000 shares to be issued   40            40 
Preferred stocks subscription receivables       E    (40)   (40)
Common stock, $0.001 par value, 100,000,000 shares authorized; 28,546,834 issued and outstanding   28,547            28,547 
Additional paid-in capital   5,396,053            5,396,053 
Accumulated deficit   (8,326,436)       (468,486)   (8,794,922)
Total Stockholders’ Equity (Deficit)   (2,901,796)       (468,526)   (3,370,322)
Total Liabilities and Stockholders’ Equity (Deficit)  $3,254,934       $(484,553)  $2,770,381 

 

 

Effect of Restatement on Consolidated Statements of Operations and Comprehensive Income

 

The following table presents the effect of the restatement adjustments on the consolidated statement of operations for the year ended December 31, 2024:

 

   As Previously Reported  

Adjustment Reference

  

Adjustment Amount

  

As

Restated

 
Revenues   -    -    -    - 
Operating expenses                    
Salaries and Employee Benefits   760,954    -    -    760,954 
Professional fees and contractors   732,676    D    (15,000)   717,676 
Depreciation and Amortization   155,118    -    -    155,118 
Other operating Expenses   86,151    F    411,202    497,353 
Total operating expenses   1,734,899    -    396,202    2,131,101 
Income (loss) from operations   (1,734,899)   -    (396,202)   (2,131,101)
Other expense                    
Interest expense   (186,700)   -    -    (186,700)
Other income   107,273    G    (72,284)   34,989 
Net other expense   (79,427)   -    (72,284)   (151,711)
Loss before provision for income taxes   (1,814,326)   -    (468,486)   (2,282,812)
Net income (loss)   (1,814,326)   -    (468,486)   (2,282,812)
Net income (loss) per common share: Basic and diluted   (0.06)        (0.02)   (0.08)
Weighted average number of common shares outstanding: Basic and diluted   28,546,834         0    28,546,834 

 

Effect of Restatement on Stockholders’ Equity

 

The following table summarizes the effect of the restatement on each component of stockholders’ equity as of December 31, 2024:

 

   As Previously Reported

   Adjustment Reference

   Adjustment Amount

  

As

Restated

 
Common Stocks   28,547    -    -    28,547 
Preferred Stocks   40    -    -    40 
Preferred stocks subscription receivables   -    -    (40)   (40)
Additional paid-in capital   5,396,053    -    -    5,396,053 
Accumulated other comprehensive income (loss)   (1,814,326)   -    (468,486)   (2,282,812)
Accumulated deficit   (8,326,436)   -    (468,486)   (8,794,922)
Total Stockholders’ Equity (Deficit)   (2,901,796)   -    (468,526)   (3,370,322)

 

Nature of Restatement Adjustments

 

Adjustment A – Corrects the Issuance of Additional Shares

 

We have corrected the second issuance of 96,250,000 common shares of Clontarf Energy per our contract. The Company did not account for the shares as they were not received but should have been recorded with a value of $38,549.

 

Adjustment B - Write-off of Uncollectable Receivable

 

The Company issued a series of loans that are deemed uncollectable with principal total of $437,597 and $85,505 interest.

 

Adjustment C - Extension of Due Date of loans

 

The extension of due date of loans resulting of reclassifying into Non-Current Liability

 

Adjustment D - Reversal of Over Accrual of Accounting Fee

 

The Company reversed an over accrual of accounting fee of $15,000 from an agreement that was previously cancelled and over payroll accrual of $1,027

 

Adjustment E - Recording of Subscription Receivables

 

The Company cancelled subscription agreements of preferred shares as the subscription agreements were not executed and payment was not received.

 

Adjustment F – Reclassification of Operating Expense

 

Write-Off $437,597 subtracting $26,395 on Unrealized Loss on Investment, previously presented in operating expenses, after adjustment it was presented in other income.

 

Adjustment G – Change to Other Income

 

Reversal of Interest income $85,505, recording of additional shares $38,549 and reclassification of $26,395 on Unrealized Loss on Investment, adjustment on preferred shares $40 and payroll $1,027